High neutrophil-lymphocyte ratio in schizophrenia independent of infectious and metabolic parameters

References

• Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, “just the facts” what we know in 2008. 2. Epidemiology and etiology. Schizophr Res. 2008;102:1–18.
   PubMed Web of Science ®Google Scholar
• Yao JK, Reddy RD, Van Kammen DP. Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs. 2001;15:287–310.
   PubMed Web of Science ®Google Scholar
• Karpiński P, Frydecka D, Sąsiadek MM, et al. Reduced number of peripheral natural killer cells in schizophrenia but not in bipolar disorder. Brain Behav Immun. 2016;54:194–200.
   PubMed Web of Science ®Google Scholar
• Turhan L, Batmaz S, Kocbiyik S, et al. The role of tumour necrosis factor alpha and soluble tumour necrosis factor alpha receptors in the symptomatology of schizophrenia. Nord J Psychiatry. 2016;70:342–350.
   PubMed Web of Science ®Google Scholar
• Schaffner KF. Variation and validation: the example of schizophrenia. World Psychiatry. 2016;15:39–40.
   PubMed Web of Science ®Google Scholar
• Potvin S, Stip E, Sepehry AA, et al. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry. 2008;63:801–808.
   PubMed Web of Science ®Google Scholar
• Muller N, J Schwarz M. The role of immune system in schizophrenia. Curr Immunol Rev. 2010;6:213–220.
   PubMedGoogle Scholar
• Zandi MS, Irani SR, Lang B, et al. Disease-relevant autoantibodies in first episode schizophrenia. J Neurol. 2011;258:686–688.
   PubMed Web of Science ®Google Scholar
• Klemettilä J-P, Kampman O, Seppälä N, et al. Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine. Nord J Psychiatry. 2017;71:89–95.
   PubMed Web of Science ®Google Scholar
• Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102:5–14.
   PubMedGoogle Scholar
• Guthrie GJ, Charles KA, Roxburgh CS, et al. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88:218–230.
   PubMed Web of Science ®Google Scholar
• Motomura T, Shirabe K, Mano Y, et al. Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. J Hepatol. 2013;58:58–64.
   PubMed Web of Science ®Google Scholar
• Kantola T, Klintrup K, Väyrynen J, et al. Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma. Br J Cancer. 2012;107:1729.
   PubMed Web of Science ®Google Scholar
• Azab B, Zaher M, Weiserbs KF, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol. 2010;106:470–476.
   PubMed Web of Science ®Google Scholar
• Chen Q, Yang L-X, Li X-D, et al. The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy. Tumor Biol. 2015;36:5283–5289.
   PubMedGoogle Scholar
• Azab B, Jaglall N, Atallah JP, et al. Neutrophil-lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis. Pancreatology. 2011;11:445–452.
   PubMed Web of Science ®Google Scholar
• Azab B, Camacho-Rivera M, Taioli E. Average values and racial differences of neutrophil lymphocyte ratio among a nationally representative sample of United States subjects. PLoS One. 2014;9:e112361.
   PubMed Web of Science ®Google Scholar
• Dickerson F, Stallings C, Origoni A, et al. C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia. Schizophr Res. 2007;93:261–265.
   PubMed Web of Science ®Google Scholar
• Fan X, Pristach C, Liu EY, et al. Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia. Psychiatry Res. 2007;149:267–271.
   PubMed Web of Science ®Google Scholar
• Miller BJ, Culpepper N, Rapaport MH. C-reactive protein levels in schizophrenia: a review and meta-analysis. Clin Schizophr Relat Psychoses. 2013;7:223–230.
   Google Scholar
• Yilmaz H, Yalcin KS, Namuslu M, et al. Neutrophil-lymphocyte ratio (NLR) could be better predictor than C-reactive protein (CRP) for liver fibrosis in non-alcoholic steatohepatitis (NASH). Ann Clin Lab Sci. 2015;45:278–286.
   PubMed Web of Science ®Google Scholar
• Kuyumcu ME, Yesil Y, Oztürk ZA, et al. The evaluation of neutrophil-lymphocyte ratio in Alzheimer’s disease. Dement Geriatr Cogn Disord. 2012;34:69–74.
   PubMed Web of Science ®Google Scholar
• Demircan F, Gözel N, Kılınç F, et al. The impact of red blood cell distribution width and neutrophil/lymphocyte ratio on the diagnosis of major depressive disorder. Neurol Ther. 2016;5:27–33.
   PubMed Web of Science ®Google Scholar
• Mayda H, Ahsen A, Bağcioğlu E, et al. Effect of increased neutrophil-to-lymphocyte ratio (NLR) and decreased mean platelet volume (MPV) values on inflammation in acute mania. Noro Psikiyatr Ars. 2016;53:317
   PubMedGoogle Scholar
• Semiz M, Yildirim O, Canan F, et al. Elevated neutrophil/lymphocyte ratio in patients with schizophrenia. Psychiat Danub. 2014;26:220–225.
   PubMed Web of Science ®Google Scholar
• Özdin S, Sarisoy G, Böke Ö. A comparison of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in schizophrenia and bipolar disorder patients–a retrospective file review. Nord J Psychiat. 2017;71:509–512.
   PubMed Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Opfer LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261.
   PubMed Web of Science ®Google Scholar
• Kostakoğlu E, Batur S, Tiryaki A, et al. Pozitif ve negatif sendrom Ölçeğinin (PANSS) Türkçe uyarlamasının geçerlik ve güvenilirliği. Türk Psikoloji Dergisi. 1999;14:23–32. Dergisi
   Web of Science ®Google Scholar
• Busner J, Steven DT. The clinical global impressions scale: applying a research tool in clinical practice Psychiatry (Edgmont). 2007;4:28–37.
   PubMedGoogle Scholar
• Expert Panel on Detection E. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486.
   PubMed Web of Science ®Google Scholar
• Kinney DK, Hintz K, Shearer EM, et al. A unifying hypothesis of schizophrenia: abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction. Med Hypotheses. 2010;74:555–563.
   PubMed Web of Science ®Google Scholar
• Monji A, Kato T, Kanba S. Cytokines and schizophrenia: microglia hypothesis of schizophrenia. Psychiatry Clin Neurosci. 2009;63:257–265.
   PubMed Web of Science ®Google Scholar
• Zhang XY, Zhou DF, Zhang PY, et al. Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology. Schizophr Res. 2002;57:247–258.
   PubMed Web of Science ®Google Scholar
• Lin A, Kenis G, Bignotti S, et al. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. Schizophr Res. 1998;32:9–15.
   PubMed Web of Science ®Google Scholar
• Katila H, Appelberg B, Hurme M, et al. Plasma levels of interleukin-1β and interleukin-6 in schizophrenia, other psychoses, and affective disorders. Schizophr Res. 1994;12:29–34.
   PubMed Web of Science ®Google Scholar
• Spangelo BL, Judd AM, Isakson PC, et al. Interleukin-6 stimulates anterior pituitary hormone release in vitro. Endocrinology. 1989;125:575–577.
   PubMed Web of Science ®Google Scholar
• Prajapati JH, Sahoo S, Nikam T, et al. Association of high density lipoprotein with platelet to lymphocyte and neutrophil to lymphocyte ratios in coronary artery disease patients. J Lipids. 2014;2014:686791.
   PubMedGoogle Scholar
• Aydin M, Yilmaz A, Donma MM, et al. Neutrophil/lymphocyte ratio in obese adolescents. North Clin Istanb. 2015;2:87
   PubMed Web of Science ®Google Scholar
• Yilmaz H, Ucan B, Sayki M, et al. Usefulness of the neutrophil-to-lymphocyte ratio to prediction of type 2 diabetes mellitus in morbid obesity. Diabetes Metab Syndr. 2015;9:299–304.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang Q, Wu H, et al. Blood neutrophil to lymphocyte ratio as a predictor of hypertension. Am J Hyperten. 2015;28:1339–1346.
   PubMed Web of Science ®Google Scholar
• Kulaksizoglu B, Kulaksizoglu S. Relationship between neutrophil/lymphocyte ratio with oxidative stress and psychopathology in patients with schizophrenia. Neuropsyc Dis Treat. 2016;12:1999.
   PubMed Web of Science ®Google Scholar
• Harvey PD, Koren D, Reichenberg A, et al. Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophr Bullet. 2005;32:250–258.
   PubMed Web of Science ®Google Scholar